News & Events

Team Develops Model to Enhance Prediction of KRAS Mutations in Patients With NSCLC

Team Develops Model to Enhance Prediction of KRAS Mutations in Patients With NSCLC

Boehringer and Vanderbilt scientists discover new GTPase KRAS inhibitors

Boehringer and Vanderbilt scientists discover new GTPase KRAS inhibitors

Revolution Medicines divulges new GTPase KRAS, NRAS and HRAS inhibitors

Revolution Medicines divulges new GTPase KRAS, NRAS and HRAS inhibitors

Another pan-KRAS project enters the clinic

Another pan-KRAS project enters the clinic

Biagio Ricciuti: Discussing immunotherapy and targeted therapy for KRAS + NSCLC

Biagio Ricciuti: Discussing immunotherapy and targeted therapy for KRAS + NSCLC

Progress Against RAS-Driven Cancers Lauded at RAS Symposium, With More Candidate Treatments on Horizon

Progress Against RAS-Driven Cancers Lauded at RAS Symposium, With More Candidate Treatments on Horizon

Lung cancer | Innovation and comprehensive care in the fight against lung cancer

Lung cancer | Innovation and comprehensive care in the fight against lung cancer

MD Anderson Researchers Identify NSCLC Patients Suited to Dual Immune Checkpoint Blockade

MD Anderson Researchers Identify NSCLC Patients Suited to Dual Immune Checkpoint Blockade

New drug could help treat tough cancers, study finds

New drug could help treat tough cancers, study finds